![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 35, 26792-26798, September 1, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Physiology and Biophysics, School of
Medicine, Case Western Reserve University, Cleveland, Ohio 44106
Received for publication, April 2, 2000, and in revised form, June 13, 2000
In human and rodent macrophages, activation of
the P2X7 nucleotide receptor stimulates interleukin-1 The P2X7 nucleotide receptor belongs to the P2X family of
ATP-gated ion channels. This family comprises seven distinct gene products, each possessing two putative membrane-spanning domains with
intracellular N and C termini (for review, see Refs. 1 and 2). The P2X7
receptor is identical to the functionally defined P2Z receptor and is
expressed primarily in hematopoietic cells and a limited number of
other cell types including parotid acinar cells, testis, and
fibroblasts (3-5). As a non-desensitizing, nonselective cation channel
with low affinity for ATP, P2X7 receptor activation requires millimolar
extracellular ATP in the presence of divalent cations. Channel opening
triggers rapid depolarization, calcium influx, and equilibration of
sodium and potassium gradients. Because individual P2X7 receptor
proteins contain only two transmembrane-spanning segments, it is
assumed that the functional channels are oligomeric complexes composed
of several individual subunits. Recent studies indicate that
recombinant P2X7 receptor subunits can self-assemble during in
vitro translation and processing into stable, detergent-resistant complexes (6). P2X7 receptor activation additionally induces a
nonselective pore able to pass molecules up to 800 Da, a characteristic shared to a lesser degree by other P2X members (7, 8). Pore structure
remains uncharacterized. The ability of heterologously expressed P2X7
receptors to reconstitute ATP-dependent channel/pore formation has been interpreted as evidence that the pore reflects either further multimerization of the P2X7 channels or a dynamic change
in the selectivity filter of P2X7 channels (9). Other data suggest that
the channel and the pore are separate entities (10).
Depending on cell background, activation of the P2X7 receptor triggers
diverse physiologic processes. For example, human monocytes primed by
bacterial endotoxin/lipopolysaccharide
(LPS)1 respond to
extracellular ATP with the caspase-1-dependent proteolytic maturation and externalization of IL-1 The stress-activated protein kinases (SAPKs; also known as JNKs)
phosphorylate and activate transcription factors such as ATF2, Ets, and
c-Jun in response to diverse cell stressors. These include UV
radiation, osmotic shock, inflammatory cytokines, and endoplasmic
reticulum stress (for review, see Refs. 24 and 25). Many of the
downstream effectors of SAPK signaling contribute to the inflammatory
response, including the TNF- Proximally, SAPKs are activated by the dual-specificity
mitogen-activated protein kinase kinases (MEKs), which in turn are activated by the MEK kinases (MEKKs). Upstream regulators of MEKK are
incompletely characterized. TNF- Materials--
All nucleotides were from Sigma, except for
2'-methylthio-ATP, which was from Research Biochemicals Inc. (Natick,
MA). Anisomycin and ouabain was from Sigma. The GST-Jun-(1-79) plasmid
was from Dr. J. Woodgett (Woods Hole Biological Laboratory).
[ Cell Culture--
The BAC1.2F5 macrophage cell line, a clone of
the SV40-transformed murine macrophage cell line BAC1, was maintained
using previously described protocols (32). Wild-type HEK293 cells and
HEK cells stably transfected with the human P2X7 receptor were
maintained as described previously (33).
SAPK Assay--
JNK activation was measured according to Kuroki
et al. (29, 30) with minor modifications. BAC1 cells (3 × 106/ml) were plated in six-well dishes. Cultures were
incubated with test agents dissolved in Iscove's Dulbecco's modified
Eagle's medium supplemented with 0.1% bovine serum albumin at
37 °C. Samples were then washed once with cold phosphate-buffered
saline and lysed with lysis buffer (25 mM HEPES (pH 7.7),
300 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA (pH 8.0), 0.1% Triton X-100, 0.5 mM
DTT, 20 mM Western Blots--
Supernatant lysates were separated by
SDS-polyacrylamide gel electrophoresis (12%) and electrophoretically
transferred to polyvinylidene difluoride membranes for 15 h at 30 mV. Polyvinylidene difluoride membranes were rinsed in immunoblot
buffer (10 mmol/liter Tris (pH 7.4), 0.9% NaCl, 0.05% Tween 20, and 1 mmol/liter EDTA) and blocked with milk buffer (4% nonfat dried milk
(Sigma) in immunoblot buffer). After washing (1 × 15 min, 2 × 5 min) with immunoblot buffer, the polyvinylidene difluoride
membranes were incubated for 1 h at room temperature with primary
antibodies dissolved in milk buffer. Both anti-JNK antiserum and
anti-phospho-specific JNK monoclonal antibody were used at 1 µg/ml.
Membranes were then washed and incubated for 1 h with 1:5000
dilutions of horseradish peroxidase-conjugated donkey anti-rabbit (for
anti-JNK antiserum) or anti-mouse (for anti-phospho-specific JNK
antibody) antibody (Amersham Pharmacia Biotech). Membranes were washed
and developed using chemiluminescent reagents (SuperSignal from Pierce)
for 0.5-5 min and exposed to Eastman Kodak x-ray film.
Measurement of DNA Fragmentation--
At appropriate time
points, 1 × 106 cells (both floating and adherent)
were centrifuged at 1500 × g for 30 s,
resuspended in 0.5 ml of lysis buffer (5 mM Tris-HCl, 20 mM EDTA, and 0.5% Triton X-100 (pH 8.0)), and placed on
ice for 15 min. Samples were then centrifuged at 12,000 × g for 20 min, and the supernatant containing DNA cleavage
products was precipitated overnight using isopropyl alcohol. Pellets
were resuspended in Tris/EDTA and digested with 0.2 mg/ml
proteinase K and 1 mg/ml RNase A for 30 min at 37 °C. DNA fragments
were separated on a 1.5% agarose gel, visualized with ethidium
bromide, and photographed.
Caspase-3-like Activity--
After challenge with appropriate
agonists, cell monolayers were washed once with 150 mM
NaCl, 20 mM Tris-HCl, and 1 mM EDTA (pH 7.5).
Cells were centrifuged for 30 s at 1500 × g, and
pellets were resuspended in lysis buffer (20 mM Tris-HCl,
150 mM NaCl, 1 mM DTT, 5 mM EDTA, 5 mM EGTA, and 1% Triton X-100 (pH 7.5)), incubated for 15 min at 37 °C, and centrifuged at 12,000 × g for 20 min. The supernatants were then stored at IL-1 SAPK Is Activated by Stimulation with Extracellular ATP--
One
of the early effects of P2X7 receptor activation is equilibration of
the trans-plasma membrane K+ and Na+
gradients. Since ionic perturbation can trigger SAPK signaling in
certain cell types, we investigated the ability of P2X7 receptors to
couple to SAPK. As an experimental approach, BAC1 murine macrophages were pulse-stimulated with extracellular ATP for relatively brief periods ranging from 10 to 30 min. Brief ATP pulses may be a more "physiologic" stimulus since tissue macrophages are likely
to be exposed to extracellular ATP for only short times due to the widespread expression of ectoapyrases, which enzymatically degrade extracellular ATP. Although removal of extracellular divalent cations
can increase P2X7 receptor affinity for ATP, tissue macrophages are
continuously exposed to millimolar levels of extracellular Mg2+ and Ca2+. For this reason, tissue culture
medium (Iscove's Dulbecco's modified Eagle's medium) containing
normal levels of divalent cations was employed in all experiments. In
the experiment illustrated in Fig. 1,
BAC1 cells were pulsed with 5 mM ATP. After a 30-min incubation, the ATP-containing medium was aspirated and replaced with
normal ATP-free Iscove's medium. At the indicated time points (Fig. 1,
A and B), cell lysates were assessed for SAPK
activity. SAPK activity was low during or immediately following the ATP pulse, but increased rapidly after ATP removal to a maximum of 4.6-fold
over basal levels. The kinase remained activated even 2 h after
ATP washout. Since continuous ATP exposure can trigger colloido-osmotic
lysis in these cells, control experiments verified that the 30-min ATP
pulse itself did not cause necrotic cell death. The cytosolic enzyme
lactate dehydrogenase was used as a marker for lysis. No increase in
lactate dehydrogenase was observed in the extracellular medium at any
point during ATP pulses (data not shown). Cells were harvested in
subsequent experiments at 60 min following the ATP pulse since the
induced SAPK activity was maximal at this time. To further characterize
the SAPK response, BAC1 cultures were challenged with ATP for different
times (0-30 min) prior to washout. Fig.
2 shows that the magnitude of SAPK activation (measured at 60 min post-ATP removal) was dependent on the
duration of the ATP pulse. A 5-min pulse was sufficient to elicit a
measurable accumulation of active SAPK, and near-maximal activation was
observed within 20 min.
The P2X7 Receptor Mediates SAPK Activation--
BAC1 macrophages
express calcium-mobilizing P2Y receptors in addition to P2Z/P2X7
receptors (34); and given the high concentration of ATP used to
activate SAPK, we next determined whether the ATP-induced SAPK activity
was mediated by the P2X7 receptor or by another P2 receptor. Fig.
3A shows that preincubation of
macrophages with periodate-oxidized ATP blocked ATP-induced SAPK
activity. In contrast, there was no inhibition of anisomycin-induced
SAPK activity, indicating that the SAPK signaling pathway remained
intact after oxidized ATP pretreatment. Western blot analysis using an
anti-SAPK antibody verified that the assay conditions did not alter
overall SAPK protein levels. Tyr and Thr phosphorylation of SAPK is
required for activity, and we verified that enzymatic kinase activity
increased in parallel with accumulation of phospho-SAPK
immunoreactivity (Fig. 3A). Although oxidized ATP inhibits
the P2X7 receptor, its specificity for the P2X7 receptor over other P2X
receptors is unclear. Therefore, we verified that the isoquinoline
derivative KN-62, a compound that also inhibits the P2X7 receptor in
BAC1 macrophages (33), completely blocked ATP-induced SAPK activity (Fig. 3B). These pharmacological data implicate the P2X7
receptor as the P2 receptor responsible for SAPK activation.
The ability of nucleotides other than ATP to activate SAPK was also
tested. Fig. 3C shows that only
3'-O-(4-benzoyl)benzoyl-ATP and ATP were SAPK agonists.
Significantly, the P2Y2 agonist UTP was without effect, ruling out a
contribution of these metabotropic P2 receptors expressed in BAC1
macrophages. The millimolar concentrations of ATP used to stimulate the
P2X7 receptor cause strong chelation of extracellular divalent cations,
and this could be contribute to the observed activation of SAPK. Since
UTP also chelates divalent cations, but does not activate P2X7
receptors, the failure of 5 mM UTP to simulate any SAPK
activity suggests that simple chelation of extracellular divalent
cations cannot explain ATP-dependent SAPK activity (Fig.
3C). The P2Y1 agonists 2'-methylthio-ATP and ADP and the P1
agonist adenosine were also ineffective at inducing SAPK activity. This
nucleotide selectivity profile is consistent with the pharmacology of
both cloned and natively expressed P2X7 receptors.
Macrophages can release various inflammatory cytokines, such as IL-1 Heterologous Expression of the P2X7 Receptor Confers ATP-sensitive
SAPK Activity--
To further investigate the relationship between
P2X7 receptor activation and the stimulation of SAPK, we compared the
abilities of ATP to activate SAPK in wild-type HEK293 cells and in an
HEK line that stably expresses the human P2X7 receptor (HEK-P2X7). To
prevent detachment of cells during ATP stimulation, HEK cells were
plated in poly-L-lysine-coated tissue culture dishes. Fig. 4A demonstrates that P2X7
receptor-transfected cells, but not the untransfected cells
(HEK-wt), were characterized by a sustained elevation of
SAPK activity following a 20-min pulse with 5 mM ATP. As a
positive control, anisomycin stimulated SAPK equally well in both cell
types. The accumulation of phosphorylated SAPK in HEK-P2X7 cells
following the 20-min ATP pulse was characterized by a time course (Fig.
4B) that was similar to the time course observed in the BAC1
macrophages (Fig. 1B), with maximal accumulation occurring
~60 min following the removal of ATP. These experiments provide
definitive evidence that the P2X7 receptor activation is sufficient for
ATP induction of SAPK activity and suggest that the signaling pathway
coupling P2X7 receptors to SAPK is not restricted to macrophages. Both
p46 and p55 forms of SAPK in the HEK cells were similarly
phosphorylated in response to P2X7 receptor activation (Fig.
4B). This contrasts with the predominant accumulation of phosphorylated p46 isoforms in the ATP-pulsed BAC1 cells (Fig. 3A). A preferential activation of p46SAPK
in mouse macrophages stimulated with TNF- Dissociation of SAPK Activation from Increased Caspase
Activity--
Caspases are ubiquitously expressed cysteine proteases
involved in the activation and execution of apoptosis (35). SAPK can be
activated by the caspase-dependent cleavage of upstream signaling molecules such as MEKK and p21-activated protein kinase (PAK) (36, 37). Since P2X7 receptor stimulation has been
associated with activation of caspase-1 and caspase-3 in other
inflammatory cell types (12, 18, 19), our findings suggested two
possibilities: 1) ATP-dependent SAPK activity is the
secondary consequence of caspase activation, or 2) SAPK activity is
upstream of caspase activation. We first verified that P2X7 receptor
activation induced both caspase-3 and caspase-1 activities in BAC1
macrophages. The 30-min ATP pulse induced time-dependent
oligonucleosomal DNA laddering (Fig.
5A). Fig. 5B shows
that DNA laddering was preceded by the breakdown of a cytoskeletal
protein,
We also verified that activation of the P2X7 receptor could stimulate
the rapid processing of pro-IL-1 P2X7 Receptor-dependent SAPK Activity Does Not Require
Caspase-1- or Caspase-3-like Activity--
Having established that ATP
pulses can induce both caspase-3 and caspase-1 activities in these
BAC1 macrophages, we next assessed whether ATP-induced SAPK
activity was caspase-dependent. Fig. 6 shows that at concentrations sufficient
to inhibit their respective proteases, neither DEVD-cho nor YVAD-cmk
had any effect on ATP-induced SAPK activity. These results indicate
that the P2Z/P2X7 receptor couples to SAPK by a caspase-3- and
caspase-1-independent mechanism.
Despite strong evidence that the P2X7 receptor regulates
macrophage apoptosis, IL-1 Although millimolar levels of extracellular ATP were required to elicit
SAPK activation, the pharmacological and nucleotide selectivity data
suggest that the P2X7 receptor alone specifically mediates this effect.
Although oxidized ATP has been extensively used as an effective P2X7
receptor antagonist, recent data suggest that this agent has multiple
P2 receptor targets (40, 41). For this reason, we also tested KN-62, an
isoquinoline derivative and
Ca2+/calmodulin-dependent protein kinase
II inhibitor first shown by Blanchard et al. (42) to
inhibit P2X7-dependent signaling. Gargett and Wiley (43)
demonstrated that this inhibition of P2X7 receptor function does not
involve Ca2+/calmodulin-dependent protein
kinase II. We have documented a strong species dependence on
KN-62 sensitivity, with the human P2X7 receptor exhibiting an
IC50 of 30 nM, the mouse receptor being
~10-fold lower less sensitive, and the rat P2X7 receptor being
virtually unaffected by this compound (33). Thus, inhibition by both
oxidized ATP and KN-62 strongly suggests that the ATP-induced SAPK
activity is mediated by the P2X7 receptor. The nucleotide selectivity
series also supports a role for this receptor as the sole mediator of
SAPK activation. The requirement for millimolar ATP and the ability of
submillimolar 3'-O-(4-benzoyl)benzoyl-ATP to mimic this
effect of ATP typify the agonist profile of the P2X7 receptor. Finally,
the inability of a caspase-1 (interleukin-converting enzyme) inhibitor
or a neutralizing anti-TNF- Although wild-type HEK293 cells natively express both P2Y1 and P2Y2
receptors (45), ATP pulsing did not trigger SAPK activation in these
cells. Rather, heterologous expression of the P2X7 receptor in HEK293
cells appears necessary and sufficient to mediate the activation of
SAPK by extracellular ATP in these fibroblast-like cells. This suggests
that the biochemical pathway linking the channel/pore to SAPK is not
restricted to macrophages. Whether P2X7 receptor expression is
sufficient to reconstitute this pathway in other cellular backgrounds
remains to be determined. Given recent data suggesting that the P2X7
receptor channel and the induced nonselective pore may be biochemically
distinct entities (10), the SAPK-inducing signal could emanate from
either the channel or the pore. It would be interesting to test whether
SAPK can be activated by maitotoxin, a pore-inducing toxin that appears to couple to the same cytolytic pore as the P2X7 receptor (44).
P2X7 receptor ligation activates caspase-1 and caspase-3 in murine
microglial cells and dendritic cells (18, 19), and our study confirms
these findings in BAC1 macrophages. Caspase inhibitors abrogate
induction of NF- The mechanism by which P2X7 receptors trigger activation of the SAPK
signaling cascade is unclear. Ca2+-dependent
activation of SAPK has been described (50). However, a simple rise in
intracellular Ca2+ is an unlikely explanation for the
ATP-mediated SAPK activation because UTP did not trigger SAPK despite
its ability to induce a sustained increase in Ca2+ in BAC1
macrophages via activation of G protein-coupled P2Y2 receptors (34).
Oxidative stressors are potent inducers of SAPK activity (53), and
reactive oxygen intermediates accumulate in microglial cell stimulated
by P2X7 receptor agonists (20). ATP-induced activation of SAPK in BAC1
macrophages was unaffected by the reducing agent
N-acetylcysteine (data not shown), making a role for
reactive oxygen intermediates less likely. Depletion of bulk
intracellular K+ is implicated in SAPK and caspase
activation as well as apoptosis and necrosis (29, 30, 51, 54).
Consistent with a possible role for K+ efflux in mediating
P2X7 receptor activation of SAPK, inhibiting K+ efflux in
BAC1 macrophages (by replacing extracellular Na+ with
K+) attenuated, but did not eliminate the ATP-mediated SAPK
activity (data not shown). Unequivocal interpretation of these
experiments is difficult because this manipulation of the extracellular
ionic conditions exerts striking effects on both the efficacy and
potency of ATP as a P2X7 receptor agonist (52).
The identification of SAPK as a P2X7 receptor effector opens new
avenues for identifying the biochemical events that underlie processes
involving the P2X7 receptor such as M. tuberculosis killing,
apoptosis, and IL-1 We are grateful to Reza Beigi and Lalitha
Gudipaty for helpful discussions.
*
This work was supported in part by National Institutes of
Health Grant GM36387.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Dept. Physiology and
Biophysics, School of Medicine E565, Case Western Reserve University,
10900 Euclid Ave., Cleveland, OH 44106-4970. Tel.: 216-368-5523; Fax:
216-368-3952; E-mail: gxd3@po.cwru.edu.
Published, JBC Papers in Press, June 14, 2000, DOI 10.1074/jbc.M002770200
The abbreviations used are:
LPS, lipopolysaccharide;
IL-1
Stress-activated Protein Kinase/JNK Activation and Apoptotic
Induction by the Macrophage P2X7 Nucleotide Receptor*
,
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
processing and
release, apoptosis, and killing of intracellular Mycobacterium
tuberculosis. Signaling pathways downstream of this
ionotropic ATP receptor are poorly understood. Here we describe
the rapid activation of the stress-activated protein kinase (SAPK)/JNK
pathway in BAC1 murine macrophages stimulated by extracellular ATP.
Brief exposure of the cells to ATP (10-30 min) was sufficient to
trigger a rapid accumulation of activated SAPK that was then sustained
for >120 min. Several observations indicated that the P2X7 receptor
mediated this effect. 1) ATP and
3'-O-(4-benzoyl)benzoyl-ATP were the only agonistic
nucleotides. 2) The effect was inhibited by oxidized ATP and the
isoquinoline KN-62, two known P2X7 receptor antagonists. 3) ATP-induced
SAPK activation could be recapitulated in P2X7 receptor-transfected
HEK293 cells, but not in wild-type HEK293 cells. Because P2X7 receptor
stimulation can rapidly activate caspase family proteases that have
been implicated in the induction of the SAPK pathway, we investigated
whether ATP-dependent SAPK activation involved such
proteases. Brief exposure of BAC1 macrophages to extracellular
ATP induced DNA fragmentation,
-fodrin breakdown, and elevated
levels of caspase-3-type activity. Asp-Glu-Val-Asp-cho, a
caspase-3 inhibitor, inhibited ATP-induced DNA fragmentation and
-fodrin proteolysis, but had no effect on ATP-induced SAPK activation. Tyr-Val-Ala-Asp-chloromethyl ketone, a caspase-1
inhibitor, prevented ATP-induced release of processed interleukin-1
,
but not ATP-dependent SAPK activity. We conclude that
activation of ionotropic P2X7 nucleotide receptors triggers a strong
activation of SAPK via a pathway independent of caspase-1- or
caspase-3-like proteases.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
(11-13). Apoptosis is
another prominent consequence of P2X7 receptor activation in various
types of leukocytes. Zanovello et al. (14) first
demonstrated ATP-dependent apoptosis in a lymphocyte cell
line, and Zheng et al. (15) confirmed this observation in
murine thymocytes. Hogquist et al. (11) later showed that
brief (30 min) exposure of thioglycolate-elicited murine peritoneal
macrophages to ATP was sufficient to initiate the signaling cascade
that leads to apoptotic death. Subsequent studies have specifically
implicated the P2X7 receptor in mediating ATP-induced apoptosis of
human macrophages, mesangial cells, dendritic cells, and microglial
cells (16-19). As with most examples of apoptosis, the P2X7
receptor-initiated cascade involves a defined sequence of phenotypic
changes that culminate in death only several hours after the transient
exposure to ATP. Agonist-occupied P2X7 receptors also drive signals
that induce nuclear accumulation of various activated transcription
factors, such as NFAT within minutes or NF-
B within hours
(20, 21). The P2X7 receptor-induced proteolytic processing and release
of IL-1
from LPS-primed macrophages also precede cell death (13).
These observations suggest that in the time period between commitment
to apoptosis and actual cell death, P2X7 receptor activation triggers
additional signals, such as NFAT activation or IL-1
release, that
modulate the overall inflammatory response of macrophages. This
possibility is supported by the observation that brief ATP pulses
trigger not only macrophage apoptosis, but also killing of
intracellular mycobacteria, including virulent Mycobacteria
tuberculosis (22). Because other inducers of macrophage apoptosis
do not kill M. tuberculosis, an as yet unidentified
P2X7-specific signal presumably induces killing of internalized
M. tuberculosis before the macrophage itself dies (16, 23).
The biochemical steps linking channel/pore activation to IL-1
release, accumulation of pro-inflammatory transcription factors,
M. tuberculosis killing, and macrophage apoptosis are poorly understood.
-dependent induction of
E-selectin, NF-
B induction in T cells, and both pro-apoptotic and
anti-apoptotic effects in a variety of cell types (24). A necessary
role of SAPK in apoptotic induction by UV irradiation, but not Fas
receptor ligation, was demonstrated in a recent study using embryonic
fibroblasts derived from double-knockout mice that lack expression of
both the Jnk1 and Jnk2 genes (55).
-dependent SAPK
activation is best described and involves recruitment of the adaptor
protein TRAF2 to the cytosolic portion of the ligated TNF-
receptor. TRAF2 mediates the activation of a series of downstream
kinases that lead to phosphorylation of SAPK itself (26). Other
intermediates have been proposed to play a role in different models of
SAPK activation, including oxidative stress, DNA damage, and caspase proteases. Altered ion fluxes have also been associated with SAPK activation in several systems. Kuroki et al. (29) described activation of SAPK by palytoxin, a natural marine toxin from
Palythoa tuberculosa that acts as a skin tumor promoter and
modulator of the Na+,K+-ATPase. Moreover,
palytoxin-induced SAPK activity requires sodium flux (30). Similarly,
UV irradiation of myeloblastic leukemia cells induces a prominent
K+ channel activation that, in turn, induces
SAPK-dependent apoptosis (31). Since a major consequence of
P2X7 receptor activation is bulk movement of both sodium and potassium,
we hypothesized that P2X7 receptor activation would activate SAPK. We
found that exposure of murine macrophages to short pulses of
extracellular ATP can rapidly induce a sustained activation of SAPK.
Pharmacological selectivity and molecular evidence indicated that the
P2X7 receptor mediates this ATP-induced kinase activity. The P2X7
receptor can activate caspases involved in either cytokine processing
or apoptotic induction (18, 19). Thus, we also evaluated the possible
involvement of caspase-1 and caspase-3 in this P2X7 receptor-induced
pathway of SAPK activation. The results indicate that although both
caspase-1 and caspase-3 were activated by the pulsed ATP protocol,
neither protease plays a role in coupling the P2X7 receptor to the
SAPK signaling cascade.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-32P]ATP was from NEN Life Science Products.
Anti-SAPK and anti-phospho-specific SAPK antibodies were from Santa
Cruz Biotechnology (Santa Cruz, CA). The anti-
-fodrin antibody was
from Chemicon International, Inc. KN-62
(1-(N,O-bis[5-isoquinolinesulfonyl]-N-methyl-L-tyrosyl)-4-phenylpiperazine) and the caspase-1 fluorogenic substrate peptide were from BIOMOL Research Labs Inc. (Plymouth Meeting, PA). The capture and detecting antibodies used for the murine IL-1
ELISA were from Endogen, Inc.
(Woburn, MA). DEVD-cho and YVAD-cmk were from Bachem California. The
caspase-3 fluorogenic substrate peptide was from Calbiochem. Recombinant murine TNF-
and a neutralizing antibody against murine TNF-
were from R&D Systems, Inc.
-glycerophosphate, 0.1 mM
Na3VO4, 2 µg/ml leupeptin, and 100 µg/ml
phenylmethylsulfonyl fluoride). Whole cell lysates were rotated for 30 min at 4 °C, followed by centrifugation at 10,000 × g for 10 min. Supernatant protein concentration was
determined by the Bradford assay (57). 50 µg of lysate was
diluted to contain 20 mM HEPES (pH 7.7), 75 mM
NaCl, 2.5 mM MgCl2, 0.1 mM EDTA,
0.05% Triton X-100, 0.5 mM DTT, 20 mM
-glycerophosphate, 0.1 mM
Na3VO4, 2 µg/ml leupeptin, and 100 µg/ml
phenylmethylsulfonyl fluoride and mixed with 10 µl of GSH-agarose
beads (Sigma) bound to the GST-Jun fusion protein. The mixture was
rotated for 2 h at 4 °C, and the beads were then washed three
times with HEPES binding buffer (20 mM HEPES (pH 7.7), 50 mM NaCl, 2.5 mM MgCl2, 0.1 mM EDTA, 0.05% Triton X-100, 0.1 mM
Na3VO4, 2 µg/ml leupeptin, and 100 µg/ml
phenylmethylsulfonyl fluoride). Beads were resuspended in 40 µl of
kinase buffer (20 mM HEPES (pH 7.6), 20 mM
MgCl2, 20 mM
-glycerophosphate, 20 mM p-nitrophenyl phosphate, 0.1 mM Na3VO4, 2 mM DTT, 20 µM ATP, and 5 µCi of [
-32P]ATP) and
incubated for 15 min at 25 °C. Proteins were eluted in SDS buffer,
boiled for 3 min, and separated by SDS-polyacrylamide gel
electrophoresis (12%). After Coomassie Blue staining, the gel was
dried and exposed to Eastman Kodak x-ray film. GST-Jun phosphorylation
was quantitated with a Bio-Rad PhosphorImager.
80 °C for future use. To
assess supernatant caspase-3-like activity, 0.3 ml of lysate was
combined with buffer (100 mM NaHEPES, 10% glycerol, 1 mM EDTA, and 5 mM DTT (pH 7.5)) and fluorogenic
caspase-3 substrate to a final concentration of 14 µM.
Fluorescence was measured at an excitation wavelength of 380 nm and an
excitation wavelength of 460 nm at 10-min intervals using a
fluorescence spectrophotometer (Perkin-Elmer). Data were plotted, and
slopes were calculated along the linear portion of the curve (at least
five separate measurements). Data are presented as the slope in
arbitrary units.
ELISA--
Macrophages were plated in 12-well dishes at
5 × 105/ml 1 day prior to challenge. On the day of
the experiment, cells were stimulated with LPS (1 µg/ml) for 4 h
to induce expression of pro-IL-1
. In certain groups, the YVAD-cmk
inhibitor was added for the final 30 min of LPS incubation. In the
continued presence of serum-containing Dulbecco's modified Eagle's
medium and LPS, cells were challenged with 3 mM ATP with or
without the YVAD-cmk inhibitor. After 60 min, 5-µl aliquots of the
tissue culture supernatant were assayed for IL-1
release by a
sandwich ELISA. Briefly, a 96-well plate was coated with 1 µg/ml
primary anti-murine IL-1
antibody overnight and then blocked with
4% bovine serum albumin in phosphate-buffered saline for 1 h.
Plates were washed three times with wash buffer (50 mM
Tris-HCl (pH 7.5) and 0.2% Tween 20). 5-µl aliquots of tissue
culture media or murine IL-1
standards, diluted with 45 µl
of Dulbecco's modified Eagle's medium, were added to the blocked
wells together with 50 µl of a second, biotinylated anti-murine
IL-1
antibody (at 0.2 µg/ml). The plates were incubated at room
temperature for 2 h and then washed three times. The captured immune complexes were colorimetrically detected by subsequent incubations with streptavidin-horseradish peroxidase conjugate and
tetramethylbenzidine substrate for horseradish peroxidase.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (14K):
[in a new window]
Fig. 1.
Treatment of murine macrophages with short
pulses of extracellular ATP induces sustained activation of SAPK.
A, BAC1 macrophages were challenged with vehicle or with 5 mM ATP for 30 min at 37 °C. The culture medium was
removed; the cells were then washed once; and fresh medium was added.
Cells were incubated at 37 °C for the indicated times and lysed, and
SAPK activity was assessed as described under "Experimental
Procedures." B, -fold SAPK activation is plotted as a
function of time for the experiment shown in A. The
solid bar from 0 to 30 min indicates the vehicle or ATP
pulse.

View larger version (19K):
[in a new window]
Fig. 2.
Relationship between ATP pulse duration and
induction of sustained SAPK activity. A, BAC1
macrophages were challenged with vehicle or with 5 mM ATP
for the indicated times; the cells were then washed once; and fresh
medium was added. After a 60-min incubation at 37 °C, cells were
lysed, and SAPK activity was assessed as described under
"Experimental Procedures." B, -fold SAPK activation is
plotted as a function of time for the experiment shown in
A.

View larger version (27K):
[in a new window]
Fig. 3.
Activation of SAPK by extracellular ATP in
macrophages is mediated by the P2X7 receptor. A, BAC1
cells were incubated at 37 °C in the absence (control) or
presence of 5 mM ATP or 200 nM anisomycin for
30 min. Cells were then washed once, and fresh medium lacking agonists
(second control and ATP) or containing 200 nM anisomycin (Aniso) was replaced.
Cells were incubated at 37 °C for 60 min before lysis. Some cells
were preincubated with the P2X7 receptor antagonist oxidized ATP
(+oATP; 300 µM) for 3 h prior to
stimulation. These groups were then challenged with ATP or anisomycin
for 30 min in the continued presence of oxidized ATP. The oxidized ATP
was not replaced after the washing step. -Fold activation of SAPK was
determined after quantitative PhosphorImager analysis of
32P incorporated into GST-Jun and normalized to the control
lane. 30 µg of lysate from the same experiment was resolved by
SDS-polyacrylamide gel electrophoresis and analyzed by Western blotting
using either an anti-JNK polyclonal antiserum (
panSAPK) or an anti-phospho-specific SAPK antibody
(
P-SAPK). B, BAC1 cells were
incubated at 37 °C in the absence (control) or presence
of 3 mM ATP or 200 nM anisomycin
(Aniso) for 30 min. 5 µM KN-62 was added to
some groups (+KN-62) along with the ATP or anisomycin. After
30 min, the cells were washed once, and fresh medium lacking agonists
(second control and ATP) or containing 200 nM anisomycin (second Aniso) was replaced in the
continued presence of KN-62. After a 60-min incubation, cells were
lysed, and SAPK activity was assessed and presented as described for
A. C, the indicated nucleotides were added to BAC1 cultures
for 30 min at 37 °C. Cells were then washed once, and fresh medium
lacking nucleotides was replaced. After the subsequent 60-min
incubation, cells were lysed, and SAPK activity was determined as
described for A. BzATP,
3'-O-(4-benzoyl)benzoyl-ATP; ADO,
adenosine; 2-meS-ATP, 2'-methylthio-ATP.
and TNF-
, which also activate SAPK signaling cascades; and these
cytokines can act as autocrine modulators of LPS-initiated macrophage
activation (56). The delayed, but sustained, activation of SAPK that
followed ATP pulsing suggested an indirect mechanism that could involve
the release and gradual extracellular accumulation of TNF-
and/or
IL-1
. However, the IL-1
and TNF-
genes are transcriptionally
silent in quiescent macrophages in the absence of primary inflammatory
stimuli such as LPS and interferon-
(56). It should be stressed that
P2X7 receptor-dependent activation of SAPK was observed in
BAC1 macrophages even in the absence of priming by LPS or
interferon-
(Figs. 1-3). Western blot analyses confirmed the
absence of IL-1
or TNF-
protein expression in either control BAC1
macrophages or cells stimulated with ATP pulses in the absence of LPS
pretreatment (data not shown); this contrasted with the marked
accumulation of these cytokines in LPS-treated BAC1 cells. The delayed
accumulation of phosphorylated SAPK triggered by ATP was not attenuated
when BAC1 macrophages were incubated with neutralizing anti-TNF-
antibodies during and following ATP pulse stimulation (data not shown).
Finally, as demonstrated in subsequent experiments (see Fig. 6 and
Table I), treatment of LPS-primed
BAC1 cells with an inhibitor of interleukin-converting enzyme/caspase-1
failed to attenuate ATP-induced SAPK activation despite strong
inhibition of the ATP-induced IL-1
secretion. These studies indicate
that release of inflammatory cytokines is an unlikely mechanism for
induction of the SAPK signaling cascade by P2X7 receptors.
Inhibition of IL-1
release by YVAD-cmk
by ELISA as described under "Experimental Procedures."
Values are means ± S.D.
has also been reported (49).

View larger version (38K):
[in a new window]
Fig. 4.
ATP-induced SAPK activity in wild-type
versus P2X7 receptor-transfected HEK293 cells.
A, wild-type HEK293 (HEK-wt) and HEK-P2X7 cells
were plated in six-well dishes coated with poly-L-lysine at
3 × 105/ml 1 day before the experiment. Cells were
challenged with 5 mM ATP for 20 min and then washed and
incubated at 37 °C for 1 h and processed. Alternatively, cells
were challenged with 10 µM anisomycin (Aniso)
for 20 min and then processed. SAPK activity was determined as
described in the legend to Fig. 1. B, HEK-P2X7 cells in
six-well dishes were challenged with 5 mM ATP for 20 min
and then washed and incubated in fresh medium for an additional 0, 30, 60, or 90 min prior to processing. Parallel wells were untreated or
treated with 10 µM anisomycin for 60 min. 40-µg
aliquots of lysate protein were resolved by SDS-polyacrylamide gel
electrophoresis and analyzed by Western blotting using either an
anti-JNK polyclonal antiserum (a-pan SAPK) or an
anti-phospho-specific SAPK antibody (a-phospho SAPK).
con, control.
-fodrin, which is a known substrate for caspase-3 during
apoptosis (38, 39). Caspase-3 activity within cell lysates (measured by
the hydrolysis of a fluorogenic substrate peptide) also increased as a
function of time following the ATP pulse (Fig. 5C). The
increase in caspase-3 activity at 3 h closely correlated with the
time course for
-fodrin breakdown, observed at 4 h after the
ATP pulse, supporting the notion that caspase-3 mediates
-fodrin
proteolysis in these cells. The amount of caspase-3 activity in cell
lysates also depended on the length of the ATP pulse (Fig.
5D) in a manner similar to that which characterized the
accumulation of active SAPK within lysates (Fig. 2, A and
B). The caspase-3 inhibitor DEVD-cho attenuated DNA
laddering in ATP-stimulated cells (Fig. 5C) and inhibited
-fodrin breakdown (Fig. 5D), supporting a role for
caspase-3 in these events.

View larger version (28K):
[in a new window]
Fig. 5.
Treatment of murine macrophages with short
pulses of extracellular ATP induces sustained activation of caspase-3
and apoptotic induction. A, BAC1 macrophages were
pulsed with 5 mM ATP for 30 min, washed, and incubated at
37 °C for the indicated times. DNA cleavage products were isolated
as described under "Experimental Procedures." B, after a
30-min, 5 mM ATP pulse, cells were incubated at 37 °C
for the indicated times. The ~240-kDa cytoskeletal protein
-fodrin
was measured using Western blot analysis of cell lysates as described
under "Experimental Procedures." The two major cleavage products at
~150 and ~120 kDa result from caspase-3-dependent
proteolysis (38, 39). C and D, in
vitro caspase-3-like protease activity was measured from cell
lysates using a fluorogenic caspase-3 substrate peptide. Cytosolic
lysates were made at the indicated times after a 5 mM ATP
pulse of either 30 min (C) or various times (D).
E, the caspase-3-like inhibitor DEVD-cho (300 µM) was added to cultures 30 min prior to a 30-min, 5 mM ATP pulse. DEVD-cho was added back to cell cultures
after washout, and DNA fragmentation was assessed 6 h after the
ATP pulse. F,
-fodrin breakdown was assessed 8 h
after a 30-min, 5 mM ATP pulse in the presence or absence
of DEVD-cho (300 µM). con, control.
to mature IL-1
in our system. In
LPS-primed macrophages, an ATP stimulus triggered the release of
processed IL-1
, as measured by ELISA-specific mature IL-1
.
Similar to previous reports, this process was mediated by the
interleukin-converting enzyme/caspase-1 because the caspase-1-like inhibitor YVAD-cmk strongly attenuated the ATP-stimulated release of
immunoreactive IL-1
(Table I).

View larger version (17K):
[in a new window]
Fig. 6.
Caspase inhibitors do not repress ATP-induced
SAPK activity. The caspase-3-like inhibitor DEVD-cho (300 µM) or the caspase-1-like inhibitor YVAD-cmk (200 µM) was added to BAC1 macrophages 30 min prior to
challenge with ATP. 5 mM ATP was added, and cells were
incubated for 30 min at 37 °C, washed with ATP-free medium
containing inhibitors, and incubated for an additional 60 min. Cells
were processed, and SAPK activity was determined as described in the
legend to Fig. 1. con, control.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
release, and killing of intracellular mycobacteria, little is known regarding the signaling pathways that
mediate these processes. This study implicates SAPK as a novel P2X7
receptor effector and represents the first demonstration of
stress-activated kinase signaling by this particular ATP-gated ion
channel. More important, this activation of SAPK was triggered using
brief pulses of extracellular ATP added to tissue culture medium
containing physiologic levels of divalent cations, conditions designed
to approximate the environment of a tissue macrophage.
antibody to attenuate stimulation of
SAPK by extracellular ATP argues against a role for secreted IL-1
or
TNF-
as an indirect mediator of this ATP effect.
B activity by P2X7 agonists, so caspases have been
proposed to mediate P2X7 receptor-dependent NF-
B
induction (20). We hypothesized that the MEKK1/MEK/SAPK pathway might
play a role in this signaling cascade because MEKK1 regulates
activation of both SAPK and NF-
B (24, 48). Moreover, caspase-3-dependent cleavage of MEKK1 into a 91-kDa
fragment increases its kinase activity and could explain why
P2X7-dependent NF-
B induction is sensitive to caspase
inhibition (27, 36). However, two lines of investigation strongly
indicate that activation of caspase-1- and caspase-3-like proteases was
not an obligatory step in the signaling pathways coupling P2X7
receptors to SAPK stimulation. First, SAPK activation preceded the
accumulation of active caspase-3 by several hours. Second, inhibitors
of either caspase-3- or caspase-1-like proteases had no effect on SAPK
activation. These peptide inhibitors blocked caspase activity as
reflected by their effects on
-fodrin breakdown and IL-1
release,
indicating that sufficient concentrations of inhibitor were used to
inactivate both proteases. One interpretation of these results is that
SAPK lies upstream of caspase activation; and indeed, SAPK has been shown to induce caspase activation (46). Alternatively, independent signaling pathways may link P2X7 receptors to the activation of SAPK
and the various caspases. Induction of apoptosis itself is a form of
cell stress that may trigger SAPK signaling without altering the
execution of the cell death program (28, 47).
release. Future studies must address both the
mechanism by which the P2X7 receptor couples to SAPK and the
physiologic consequences of activating this signaling pathway.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
Supported by Medical Scientist Training Program Grant GM07250-24
from the National Institutes of Health.
![]()
ABBREVIATIONS
, interleukin-1
;
SAPK, stress-activated
protein kinase;
JNK, c-Jun N-terminal kinase;
TNF-
, tumor necrosis
factor-
;
MEK, mitogen-activated protein kinase/extracellular
signal-regulated kinase kinase;
MEKK, MEK kinase;
GST, glutathione
S-transferase;
ELISA, enzyme-linked immunosorbent assay;
DEVD-cho, Asp-Glu-Val-Asp-cho;
YVAD-cmk, Tyr-Val-Ala-Asp-chloromethyl ketone;
HEK, human embryonic
kidney;
DTT, dithiothreitol;
cho, aldehyde;
NFAT, nuclear factor of
activated T cells;
TRAF, tumor necrosis factor receptor-associated
factor.
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
North, R. A.,
and Barnard, E. A.
(1997)
Curr. Opin. Neurobiol.
7,
346-357
2.
Evans, R. J.,
Surprenant, A.,
and North, R. A.
(1998)
in
The P2 Nucleotide Receptors
(Turner, J. T.
, Weisman, G. A.
, and Fedan, J. S., eds)
, pp. 43-61, Humana Press Inc., Totowa, NJ
3.
Collo, G.,
Neidhart, S.,
Kawashima, E.,
Kosco-Vilbois, M.,
North, R. A.,
and Buell, G.
(1997)
Neuropharmacology
36,
1277-1283
4.
Tenneti, L.,
Gibbons, S. J.,
and Talamo, B. R.
(1998)
J. Biol. Chem.
273,
26799-26808
5.
Solini, A.,
Chiozzi, P.,
Morelli, A.,
Fellin, R.,
and Di Virgilio, F.
(1999)
J. Cell Sci.
112,
297-305
6.
Torres, G. E.,
Egan, T. M.,
and Voigt, M. M.
(1999)
J. Biol. Chem.
274,
6653-6659
7.
Virginio, C.,
Mackenzie, A.,
Rassendren, F. A.,
North, A.,
and Surprenant, A.
(1999)
Nat. New Biol.
2,
315-321
8.
Khakh, B. S.,
and Lester, H. A.
(1999)
Neuron
23,
653-658
9.
Khakh, B. S.,
Bao, X. R.,
Labarca, C.,
and Lester, H. A.
(1999)
Nat. Neurosci.
2,
322-330
10.
Schilling, W. P.,
Waslyna, T.,
Dubyak, G. R.,
Humphreys, B. D.,
and Sinkins, W. G.
(1999)
Am. J. Physiol.
277,
C766-C776
11.
Hogquist, K. A.,
Nett, M. A.,
Unanue, E. R.,
and Chaplin, D. D.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
8485-8491
12.
Perregaux, D.,
and Gabel, C. A.
(1994)
J. Biol. Chem.
269,
15195-15203
13.
Ferrari, D.,
Chiozzi, P.,
Falzoni, S.,
Dal Susino, M.,
Melchiorri, L.,
Baricordi, O. R.,
and Di Virgilio, F.
(1997)
J. Immunol.
159,
1451-1458
14.
Zanovello, P.,
Bronte, V.,
Rosato, A.,
Pizzo, P.,
and Di Virgilio, F.
(1990)
J. Immunol.
145,
1545-1556
15.
Zheng, L. M.,
Zychlinsky, A.,
Liu, C. C.,
Ojcius, D. M.,
and Young, J. D.
(1991)
J. Cell Biol.
112,
279-288
16.
Lammas, D. A.,
Stober, C.,
Harvey, C. J.,
Kendrick, N.,
Panchalingam, S.,
and Kumararatne, D. S.
(1997)
Immunity
7,
433-444
17.
Schulze-Lohoff, E., Hugo, C., Rost S., Arnold, S., Gruber, A., Brune,
B., and Sterzel, R. B. (1998) Am. J. Physiol.
F962-F971
18.
Coutinho-Silva, R.,
Persechini, P. M.,
Da Cunha Bisaggio, R.,
Perfettini, J.,
Torres de Santo, A. C.,
Kanellopoulos, J. M.,
Mottaly, I.,
Dautry-Varsat, A.,
and Ojcius, D. M.
(1999)
Am. J. Physiol.
276,
C1139-C1147
19.
Ferrari, D.,
Los, M.,
Bauer, M. K.,
Vandenabeele, P.,
Wesselborg, S.,
and Schulze-Osthoff, K.
(1999)
FEBS Lett.
447,
71-75
20.
Ferrari, D.,
Wesselborg, S.,
Bauer, M.,
and Schulze-Osthoff, K.
(1997)
J. Cell Biol.
139,
1635-1643
21.
Ferrari, D.,
Stroh, C.,
and Schulze-Osthoff, K.
(1999)
J. Biol. Chem.
274,
13205-13210
22.
Kusner, D. J.,
and Adams, J.
(2000)
J. Immunol.
164,
379-388
23.
Molloy, A.,
Laochumroonvorapong, P.,
and Kaplan, G.
(1994)
J. Exp. Med.
180,
1499-1509
24.
Ip, Y. T.,
and Davis, R. J.
(1998)
Curr. Opin. Cell Biol.
10,
205-219
25.
Kyriakis, J. M.,
and Avruch, J.
(1996)
J. Biol. Chem.
271,
24313-24316
26.
Shi, C. S,
and Kehrl, J. H.
(1997)
J. Biol. Chem.
272,
32102-32107
27.
Widmann, C.,
Gerwins, P.,
Johnson, N. L.,
Jarpe, M. B.,
and Johnson, G. L.
(1998)
Mol. Cell. Biol.
18,
2416-2429
28.
Ozaki, I.,
Tani, E.,
Ikemoto, H.,
Kitagawa, H.,
and Fujikawa, H.
(1999)
J. Biol. Chem.
274,
5310-5317
29.
Kuroki, D. W.,
Bignami, G. S.,
and Wattenberg, E. V.
(1996)
Cancer Res.
56,
637-644
30.
Kuroki, D. W.,
Minden, A.,
Sanchez, I.,
and Wattenberg, E. V.
(1997)
J. Biol. Chem.
272,
23905-23911
31.
Wang, L.,
Xu, D.,
Dai, W.,
and Lu, L.
(1999)
J. Biol. Chem.
274,
3678-3685
32.
el-Moatassim, C.,
and Dubyak, G. R.
(1992)
J. Biol. Chem.
267,
23664-23673
33.
Humphreys, B. D.,
Virginio, C.,
Surprenant, A.,
Rice, J.,
and Dubyak, G. R.
(1998)
Mol. Pharmacol.
54,
22-32
34.
Humphreys, B. D.,
and Dubyak, G. R.
(1996)
J. Immunol.
157,
5627-5637
35.
Cohen, G. M.
(1997)
Biochem. J.
326,
1-16
36.
Cardone, M. H.,
Salvesen, G. S.,
Widmann, C.,
Johnson, G.,
and Frisch, S. M.
(1997)
Cell
90,
315-323
37.
Rudel, T.,
and Bokoch, G. M.
(1997)
Science
276,
1571-1574
38.
Martin, S. J.,
O'Brien, G. A,
Nishioka, W. K.,
McGahon, A. J.,
Mahboubi, A.,
Saido, T. C.,
and Green, D. R.
(1995)
J. Biol. Chem.
270,
6425-6428
39.
Janicke, R. U.,
Ng, P.,
Sprengart, M. L.,
and Porter, A. G.
(1998)
J. Biol. Chem.
273,
15540-15545
40.
Surprenant, A.
(1996)
CIBA Found. Symp.
198,
208-219
41.
Sikora, A.,
Liu, J.,
Brosnan, C.,
Buell, G.,
Chessel, I.,
and Bloom, B. R.
(1999)
J. Immunol.
163,
558-561
42.
Blanchard, D. K.,
Hoffman, S. L.,
and Djeu, J. Y.
(1995)
J. Cell. Biochem.
57,
452-461
43.
Gargett, C. E.,
and Wiley, J. S.
(1997)
Br. J. Pharmacol.
120,
1483-1490
44.
Schilling, W. P.,
Sinkins, W. G.,
and Estacion, M.
(1999)
Am. J. Physiol.
277,
C755-C765
45.
Schachter, J. B.,
Sromek, S. M.,
Nicholas, R. A.,
and Harden, T. K.
(1997)
Neuropharmacology.
36,
1181-1187
46.
Seimiya, H.,
Mashima, T.,
Toho, M.,
and Tsuruo, T.
(1997)
J. Biol. Chem.
272,
4631-4636
47.
Potapova, O.,
Haghigi, A.,
Bost, F.,
Liu, C.,
Birrer, M. J.,
Gjerset, R.,
and Mercola, D.
(1997)
J. Biol. Chem.
272,
14041-14044
48.
Lee, F. S.,
Hagler, J.,
Chen, Z. J.,
and Maniatis, T.
(1997)
Cell
88,
213-222
49.
Chan, E. D.,
Winston, B. W.,
Jarpe, M. B.,
Wynes, M. W.,
and Riches, D. W. H.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
13169-13174
50.
Enslen, H.,
Tokumitsu, H.,
Stork, P. J.,
Davis, R. J.,
and Soderling, T. R.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
10803-10808
51.
Bortner, C. D.,
Hughes, F. M., Jr.,
and Cidlowski, J. A.
(1997)
J. Biol. Chem.
272,
32436-32442
52.
Michel, A. D.,
Chessell, I. P.,
and Humphrey, P. P.
(1999)
Naunyn-Schmiedebergs Arch. Pharmakol.
359,
102-109
53.
Iordanov, M. S.,
and Magun, B. E.
(1999)
J. Biol. Chem.
274,
25801-25806
54.
Warny, M.,
and Kelly, C. P.
(1999)
Am. J. Physiol.
276,
C717-C724
55.
Tournier, C.,
Hess, P.,
Yang, D. D.,
Xu, J.,
Turner, T. K.,
Nimnual, A.,
Bar-Sagi, D.,
Jones, S. N,
Flavell, R. A.,
and Davis, R. J.
(2000)
Science
288,
870-874
56.
Ulevitch, R. J.,
and Tobias, P. S.
(1995)
Annu. Rev. Immunol.
13,
437-457
57.
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
T. Noguchi, K. Ishii, H. Fukutomi, I. Naguro, A. Matsuzawa, K. Takeda, and H. Ichijo Requirement of Reactive Oxygen Species-dependent Activation of ASK1-p38 MAPK Pathway for Extracellular ATP-induced Apoptosis in Macrophage J. Biol. Chem., March 21, 2008; 283(12): 7657 - 7665. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Guo, M. Masin, O. S. Qureshi, and R. D. Murrell-Lagnado Evidence for Functional P2X4/P2X7 Heteromeric Receptors Mol. Pharmacol., December 1, 2007; 72(6): 1447 - 1456. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. B. Choi, J. K. Ryu, S. U. Kim, and J. G. McLarnon Modulation of the Purinergic P2X7 Receptor Attenuates Lipopolysaccharide-Mediated Microglial Activation and Neuronal Damage in Inflamed Brain J. Neurosci., May 2, 2007; 27(18): 4957 - 4968. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Fernando, B. M. Saunders, R. Sluyter, K. K. Skarratt, H. Goldberg, G. B. Marks, J. S. Wiley, and W. J. Britton A Polymorphism in the P2X7 Gene Increases Susceptibility to Extrapulmonary Tuberculosis Am. J. Respir. Crit. Care Med., February 15, 2007; 175(4): 360 - 366. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Douillet, W. P. Robinson III, P. M. Milano, R. C. Boucher, and P. B. Rich Nucleotides induce IL-6 release from human airway epithelia via P2Y2 and p38 MAPK-dependent pathways Am J Physiol Lung Cell Mol Physiol, October 1, 2006; 291(4): L734 - L746. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chen and C. F. Brosnan Exacerbation of Experimental Autoimmune Encephalomyelitis in P2X7R-/- Mice: Evidence for Loss of Apoptotic Activity in Lymphocytes. J. Immunol., March 1, 2006; 176(5): 3115 - 3126. [Abstract] [Full Text] [PDF] |